Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic compositions for age-related macular degeneration comprising a complement factor H with isoleucine at residue 62 and tyrosine at residue 402

Therapeutic compositions for age-related macular degeneration comprising a complement factor H with isoleucine at residue 62 and tyrosine at residue 402

US Patent 8497350 · Granted Jul 30, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and reagents for treatment of age-related macular degeneration2021
Variants in complement regulatory genes predict age-related macular degeneration2015
Complement factor H for diagnosis of age-related macular degeneration2012
Variants in complement regulatory genes predict age-related macular degeneration2011
Methods and reagents for treatment and diagnosis of vascular disorders and age-r2011
Methods for treatment of age-related macular degeneration2010
Diagnostics and therapeutics for macular degeneration-related disorders2010
Diagnostics and therapeutics for macular degeneration-related disorders2008
Diagnostics and therapeutics for macular degeneration-related disorders2008
Nucleic acids encoding interphotoreceptor matrix proteins2007
Diagnostics and the therapeutics for macular degeneration2006
Diagnostics and therapeutics for macular degeneration-related disorders2006